Market

Truist Securities initiates Immunovant stock with Hold rating, $16 target

Truist Securities initiates Immunovant stock with Hold rating, $16 target
Read More

Related Posts

Carvana gets a spot in the S&P 500 ahead of these tech stocks

Carvana gets a spot in the S&P 500 ahead of these tech ...

Treasury market logs worst weekly rout since April, in a bad sign for borrowers

Treasury market logs worst weekly rout since April, in ...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...

This crazy chart shows just how much cash OpenAI is burning as it chases AI profits

This crazy chart shows just how much cash OpenAI is bur...